Hepatitis virus infection and hodgkin’s lymphoma: A review of the literature

Hepatitis Monthly

Volumn 7, Issue 4, 2007, Pages 229-231

  Wiwanitkit, Viroj ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Hepatitis C; Hepatitis G; Hodgkin s lymphoma

Indexed keywords

CD81 ANTIGEN;

HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS G; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; LIVER CELL CARCINOMA; META ANALYSIS (TOPIC); NONHUMAN; REVIEW; RISK FACTOR; TORQUE TENO VIRUS 1;

EID: 80054966440     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Keresztes K, Takacs M, Horanyi M, Miltenyi Z, Illes A. HCV and HGV infection in Hodgkin’s disease. Pathol Oncol Res 2003; 9: 222-5.
2. Fisher SG, Fisher RI. The epidemiology of non-Hodgkin’s lymphoma. Oncogene 2004; 23: 6524-34.
3. Takada K. Virus-associated malignancies (in Japanese). Ryoikibetsu Shokogun Shirizu 1999; 25: 421-4.
4. Chow VT. Cancer and viruses. Ann Acad Med Singapore 1993; 22: 163-9.
5. Kato N. Hepatitis C virus as a causative agent of carcinogenesis--recent trends for study (in Japanese). Nippon Rinsho 1997; 55: 3051-62.
6. Shimotohno K. Hepatitis C virus as a causative agent of hepatocellular carcinoma. Intervirology 1995; 38: 162-9.
7. Hausfater P, Rosenthal E, Cacoub P. Lymphoproliferative diseases and hepatitis C virus infection (in French). Ann Med Interne (Paris) 2000; 151: 53-7.
8. Schulze zur Wiesch J, Schmitz H, Borowski E, Borowski P. The proteins of the Hepatitis C virus: their features and interactions with intracellular protein phosphorylation. Arch Virol 2003; 148: 1247-67.
9. Quinn ER, Chan CH, Hadlock KG, Foung SK, Flint M, Levy S. The B-cell receptor of a hepatitis C virus (HCV)- associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 2001; 98: 3745-9.
10. Montella M, Crispo A, Frigeri F, Ronga D, Tridente V, De Marco M, et al. HCV and tumors correlated with immune system: a case-control study in an area of hyperendemicity. Leuk Res 2001; 25: 775-81.
11. Fiorilli M, Mecucci C, Farci P, Casato M. HCV-associated lymphomas. Rev Clin Exp Hematol 2003; 7: 406-23.
12. Yenice N, Gulluk F, Arican N, Turkmen S. HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases. Turk J Gastroenterol 2003; 14: 173-6.
13. Wiwanitkit V. Summary on the seroprevalence of hepatitis C among patients with Hodgkin’s lymphoma, an implication for risk by metanalysis. Shiraz E-Medical Journal 2007; 8: 1.
14. Sehgal R, Sharma A. Hepatitis G virus (HGV): current perspectives. Indian J Pathol Microbiol 2002; 45: 123-8.
15. Stapleton JT. GB virus type C/Hepatitis G virus. Semin Liver Dis 2003; 23: 137-48.
16. De Renzo A, Persico E, de Marino F, di Giacomo Russo G, Notaro R, di Grazia C, et al. High prevalence of hepatitis G virus infection in Hodgkin’s disease and B-cell lymphoproliferative disorders: absence of correlation with hepatitis C virus infection. Haematologica 2002; 87: 714-8.
17. Persico M, De Renzo A, Persico E, Notaro R, Torella R, Rotoli B. Hepatitis G virus in patients with Hodgkin’s lymphoma. Br J Haematol 1998; 103: 1206-7.
18. Garbuglia AR, Iezzi T, Capobianchi MR, Pignoloni P, Pulsoni A, Sourdis J, et al. Detection of TT virus in lymph node biopsies of B-cell lymphoma and Hodgkin’s disease, and its association with EBV infection. Int J Immunopathol Pharmacol 2003; 16: 109-18.